Brief: Solid Biosciences Presents New Sgt-001 Ignite Dmd Study Results At World Muscle Society 2022 Congress Demonstrating Improvements In Ambulatory Function

Solid Biosciences

13/10/2022 13:06

Oct 13 (Reuters) - Solid Biosciences Inc  SLDB.O :
    * SOLID BIOSCIENCES PRESENTS NEW SGT-001 IGNITE DMD STUDY
RESULTS
AT WORLD MUSCLE SOCIETY 2022 CONGRESS DEMONSTRATING IMPROVEMENTS
IN AMBULATORY FUNCTION
    * SOLID BIOSCIENCES - SV95C DATA SHOW IMPROVEMENTS AT
ONE-YEAR
POST-DOSING COMPARED WITH DECLINES OBSERVED IN CONTROL AND
NATURAL HISTORY PATIENTS
    * SOLID BIOSCIENCES - INTEND TO INCLUDE SV95C AS ENDPOINT IN
CLINICAL EVALUATION OF SGT-003, WHICH IS EXPECTED TO COMMENCE IN
LATE-2023

Source text for Eikon:  ID:nGNX3dnCnx 
Further company coverage:  SLDB.O 
 ((Reuters.Briefs@thomsonreuters.com;))